Teva introduces authorized generic birth-control pill

Teva Pharmaceuticals announced in a prepared statement that levonorgestrel/ethinyl estradiol and ethinyl estradiol tablets (Camrese Lo) are now available.

The tablets are available in a strength of 0.1 mg/0.02 mg; 0.01 mg, in a 2x91-tablet dispenser. This product is the authorized generic version of the LoSeasonique tablets offered by the company.

“Our customers count on Teva for a continuous supply of new generic products,” said Maureen Cavanaugh, vice president, customer operations and marketing. “With the launch of Camrese Lo, we add another quality product to our broad line of affordable generic pharmaceuticals.”

Camrese is indicated for use by women to prevent pregnancy. One tablet is to be taken by mouth at the same time every day. To achieve maximum contraceptive effectiveness, Camrese must be taken exactly as directed and at intervals not exceeding 24 hours. Common side effects include spotting or bleeding between menstrual periods, nausea, breast tenderness, and headache. Women who smoke cigarettes and are age 35 or older should not use this product.